Biotech is still one of the most exciting sectors on the market. Recession-proof, the sector is still thriving with millions of retiring baby boomers, mergers and acquisitions, new innovation, the introduction of artificial intelligence with drug discovery and demand for new treatments.
Plus, with industry heavyweights nearing patent expirations, many are on the hunt for fresh new ideas — great news for biotech stocks to buy with strong pipelines.
This post appeared first on InvestorPlace.